Organization
Nanjing Geneseeq Technology Inc.
10 abstracts
Abstract
Utility of liquid biopsy for predicting cancer type and informing treatment of carcinoma with unknown primary.Org: Geneseeq Research Institute, Nanjing Geneseeq Technology Inc.,
Abstract
Molecular characterization and biomarker identification in pediatric B-cell acute lymphoblastic leukemia.Org: Nanjing Geneseeq Technology Inc., Geneseeq Research Institute,
Abstract
Multi-dimensional cell-free DNA-based liquid biopsy for sensitive detection of head and neck squamous cell carcinomas.Org: Geneseeq Research Institute, Nanjing Geneseeq Technology Inc.,
Abstract
A liquid biopsy-based assay for classifying breast cancer from benign nodule.Org: Breast Center, The Fourth Hospital of Hebei Medical University, Geneseeq Research Institute, Nanjing Geneseeq Technology Inc.,
Abstract
Early detection, clinicopathological subtyping and prognosis prediction for patients with endometrial cancer using fragmentoimcs-based liquid-biopsy assay.Org: Department of Gynecologic Oncology, Gynecology and Obstetrics Center, The First Hospital of Jilin University, Changchun, China, Sun Yat-sen Memorial Hospital of SunYat-sen University, Guangzhou, China, Sun Yat-sen University Cancer Center Gansu Hospital, Guangzhou JOYO Pharma, China National Biotec Group,
Abstract
A pilot phase II trial of neoadjuvant camrelizumab plus nab-paclitaxel and cisplatin (NeoCPC) for locoregionally advanced, resectable squamous cell carcinoma of the head and neck.Org: Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China, Collaborative Innovation Center for Cancer Medicine, Department of Otolaryngology Head and Neck Surgery, The Fifth Affiliated Hospital of Guangzhou Medical University,
Abstract
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.Org: Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Sun Yat-sen Memorial Hospital of SunYat-sen University, Guangzhou, China, Sun Yat-sen University Cancer Center Gansu Hospital,
Abstract
Mechanisms of resistance to tyrosine kinase inhibitor treatments in patients with ROS1 fusion-positive non-small cell lung cancer.Org: Department of Thoracic Medical Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Fudan University Shanghai Cancer Center, Geneseeq Research Institute, Nanjing Geneseeq Technology Inc.,
Abstract
ctDNA for clonal evolution surveillance and therapeutic efficacy prediction in unresectable locally advanced non-small cell lung cancer under radiotherapy.Org: Geneseeq Research Institute, Nanjing Geneseeq Technology Inc.,
Abstract
Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer.Org: Nanjing Geneseeq Technology Inc., Geneseeq Research Institute,